昭衍新药：董事顾晓磊及其一致行动人顾美芳拟合计减持不超2.31%

array(1) { [398208]=> array(2) { [2]=> array(4) { [0]=> string(12) "股东减持" [1]=> string(12) "高管减持" [2]=> string(12) "董事减持" [3]=> string(12) "昭衍新药" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }